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Antibiotic-associated infections with Clostridioides difficile are a severe and
often lethal risk for hospitalized patients, and can also affect populations
without these classical risk factors. For a rational design of therapeutical
concepts, a better knowledge of the metabolism of the pathogen is crucial.
Metabolic modeling can provide a simulation of quantitative growth and
usage of metabolic pathways, leading to a deeper understanding of the
organism. Here, we present an elaborate genome-scale metabolic model of
C. difficile 630Derm. The model iHD992 includes experimentally deter-
mined product and substrate uptake rates and is able to simulate the
energy metabolism and quantitative growth of C. difficile. Dynamic flux
balance analysis was used for time-resolved simulations of the quantitative
growth in two different media. The model predicts oxidative Stickland
reactions and glucose degradation as main sources of energy, while the
resulting reduction potential is mostly used for acetogenesis via the Wood–
Ljungdahl pathway. Initial modeling experiments did not reproduce the
observed growth behavior before the production of large quantities of a
previously unknown polysaccharide was detected. Combined genome anal-
ysis and laboratory experiments indicated that the polysaccharide is an
acetylated glucose polymer. Time-resolved simulations showed that
polysaccharide secretion was coupled to growth even during unstable glu-
cose uptake in minimal medium. This is accomplished by metabolic shifts
between active glycolysis and gluconeogenesis which were also observed in
laboratory experiments.
Clostridioides difficile (previously Clostridium difficile
[1,2]) is a rod-shaped, Gram-positive, spore-forming
bacterium of the Clostridiales order and represents a
major cause of infectious diarrhea developed after
antibiotic treatment during hospitalization. The symp-
toms of C. difficile infection can range from mild diar-
rhea to pseudomembraneous colitis and toxic
megacolon, bowel perforation, and sepsis [3].
Clostridioides difficile can carry two large clostridial
toxins named toxin A and toxin B as well as an actin-
specific ADP-ribosyltransferase better known as binary
toxin [4]. Strains with the binary toxin but deficient
for the other toxins are still virulent [5]. Nevertheless,
the toxins A and B are considered to be the main viru-
lence factors [6]. The production of the large toxins is
known to be regulatory connected to the metabolism
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and strongly environment-dependent [7–10]. This con-
nection between metabolism and virulence illustrates
the need of a deep understanding of the metabolism.
The metabolism of C. difficile is strongly dependent on
Stickland reactions, which involve the coupled oxida-
tion and reduction of amino acids to short-chain
organic acids [11]. Figure 1 shows the leucine degrada-
tion pathways in C. difficile, which are classical exam-
ples for oxidative and reductive Stickland pathways.
As the metabolism is based on the genome, the first
sequencing of a strain in 2006 [12] opened new ways
to characterize C. difficile. The erythromycin-sensitive
mutant strain 630Derm [13] was sequenced in 2014 [14]
and is currently one of the most popular research
strains of C. difficile. Recently, we published time-
resolved exometabolome data [10] and the resequenc-
ing and reannotation of this strain [15]. Due to the
availability of these data, strain 630Derm is the perfect
candidate for metabolic modeling.
Genome-scale metabolic modeling can be used for a
wide range of predictions. It can help to interpret
experimental data or predict nutritional requirements,
quantitative growth performance, mutant growth, and
even proton transport stoichiometry [16]. We used the
so called constraint-based stoichiometric flux balance
analysis (FBA). In principle, the metabolic concentra-
tions and fluxes can be mathematically described by
ordinary differential equations describing the produc-
tion and consumption rates of all metabolites by accu-
rate stoichiometric reaction equations. Assuming – at
least for a short time – a flux equilibrium where con-
centrations do not change as long as outer conditions
or the protein repertoire is not changing, this reduces
to a linear equation system. As there are more fluxes
than metabolites in the cell, this equation system is
underdetermined and can be solved by introducing
constraints and applying biological knowledge about
optimized use of nutrients during evolution. So, in
most cases that combination of fluxes is calculated that
maximizes the biomass production.
The prediction of quantitative growth in batch cul-
tures has been done previously for Escherichia coli in a
glucose minimal medium using dynamic flux balance
analysis (DFBA) [17,18]. Using experimentally
acquired maximum uptake rates for glucose and oxy-
gen, the simulations reproduced the experimental
results quite accurately with the growth either limited
by oxygen (aerobic scenario) or by the sole carbon
A
B
Fig. 1. Leucine degradation in C. difficile,
an example for classical Stickland
degradation [65]. (A) Oxidative Stickland
pathway. (B) Reductive Stickland pathway.
Electron bifurcation of the 2-isocaprenoyl-
CoA hydrogenase was assumed based on
homology [32–34].
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source glucose (anaerobic scenario). The anaerobic
growth in combination with the need of several carbon
sources prohibits an approach based on maximum
uptake rates for C. difficile. An initial metabolic model
of C. difficile 630 was published by Larocque et al.
[19] and used to predict essential genes by computa-
tional knockout analysis to find drug targets [19].
Here, we present an improved and elaborate gen-
ome-scale metabolic model iHD992 of C. difficile
630Derm, which consist of 992 genes, 786 reactions,
936 metabolites, and 163 transport reactions. It
includes time-resolved substrate uptake and biomass
production rates, derived from laboratory data, as well
as the production and secretion of a previously unde-
scribed polysaccharide. The identity of the polysaccha-
ride is determined based on combined bioinformatical
analysis and laboratory experiments. In addition,
DFBA is used for quantitative and time-resolved simu-
lation of batch cultures in minimal defined medium
(MDM) and C. difficile defined minimal medium
(CDMM). Both media consist of glucose as well as the
same salts and buffers. MDM also contains seven
amino acids strictly necessary for growth (cysteine,
methionine, proline, leucine, isoleucine, valine, and
tryptophan), while CDMM is a richer medium that
includes casamino acids, cysteine, and tryptophan [10].
The shifts between glycolysis and gluconeogenesis in
MDM, experimentally shown with isotope-labeled glu-
cose, are explained based on modeling results. Finally,
the importance of the one-carbon metabolism as well
as the fragmented tricarboxylic acid (TCA) cycle are
discussed in detail.
Results and Discussion
The metabolic model iHD992
The model iHD992 of C. difficile 630Derm consists of
992 genes, 786 reactions, 936 metabolites, and 163
transport reactions. The model is included in the Sup-
porting information (Model S1 and the exemplary Sce-
nario S1). In comparison to the published model
iMLTC806cdf of C. difficile 630 [19], our model con-
tains more reactions, metabolites, and genes (Table 1).
These include mainly pathways specific for C. difficile
(e.g., bile acid metabolism).
Genome-scale metabolic models contain reactions
based on genome annotations, spontaneous reactions,
and reactions neither based on the genome nor known
to be spontaneous. While reactions in the first two
groups form the core of each model, the number of
reactions in the latter group should be low. These
reactions are usually added to the model to close gaps
in the metabolic pathways which are known or
assumed to be functional in the organism. For exam-
ple, this is the case for described pathways whose
enzymes are not yet identified. In our model, we could
decrease the number of these reactions compared to
iMLTC806cdf by 83%, representing a significant
improvement.
The two C. difficile models are significantly different
as they share only 508 metabolic reactions (67% of
iMLTC806cdf), while the model by Larocque et al.
has 385 (51%) in common with the Clostridium aceto-
butylicum model iCAC490 [19,20]. Of the 262 other
metabolic reactions from iMLTC806cdf, 111 are not
existing in iHD992 as they are not sequence based
reactions and no other indication could be found for
their existence in C. difficile. From the 151 sequence-
based reactions in the model from Larocque et al. not
existing in iHD992, 140 are not in iHD992 because of
differences in enzyme function predictions, six were
excluded from iHD992 as they are metabolically
cheaper side reactions compared to the main reactions
of the enzymes and five were excluded as these would
lead to the cost-free reduction of NADP+ with
NADH.
The published model iMLTC806cdf [19] was tested
in an exemplary MDM growth scenario with the sub-
strate consumption rates derived from our experiment
at 3 h of cultivation and biomass production as the
objective function. The model permits cost-free energy
generation (e.g., free secretion of protons in
combination with the ATP synthase). The growth is
nevertheless limited by the L-leucine uptake as the
model predicts C. difficile to be leucine auxotroph.
The resulting predicted growth rate of 7.12 h1 is sig-
nificantly higher as the experimentally determined
0.414 h1. This finding indicates the inability of the
model iMLTC806cdf to describe the energy metabo-
lism and quantitative growth of C. difficile.
Table 1. Comparison of the C. difficile models iHD992 and
iMLTC806cdf.
Model iHD992 iMLTC806cdf [19]
Strain 630Derm 630
Metabolic reactions 786 760
Not sequence-based 44 149
Spontaneous 20 8
Nonspontaneous 24 141
Transport reactions 163 145
Exchange reactions 161 171
Biomass reactions 15 9
Metabolites 936 704
Genes 992 806
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The incomplete tricarboxylic acid cycle
Based on our genome annotation, C. difficile 630Derm
has a fragmented TCA cycle (Fig. 2), which is still
capable to produce necessary biomass precursors and
degrade side products of biosynthesis, but no direct
connection is existent between 2-oxoglutarate and suc-
cinyl-CoA. The reductive direction from oxaloacetate
to L-malate is also blocked as no nondecarboxylating
L-malate dehydrogenase (like EC 1.1.1.37) could be
identified in C. difficile. The metabolites from L-malate
to succinyl-CoA are nevertheless connected to the
metabolism via L-aspartate. It serves as ammonium
donor for the arginine and IMP biosyntheses and is
converted to fumarate. Fumarate can be degraded to
pyruvate by the fumarate hydratase (EC 4.2.1.2) and
malate dehydrogenase (oxaloacetate-decarboxylating)
(EC 1.1.1.38) or used as electron acceptor in the oxida-
tion of L-aspartate to produce iminosuccinate for the
NAD+ biosynthesis. The resulting succinate fills
the intracellular succinate/succinyl-CoA pool for the
methionine biosynthesis. Succinate can be recycled
by the succinyl-CoA:acetate CoA-transferase (EC
2.8.3.18) or degraded to butanoate. A similar TCA
cycle was previously described for the close relative
C. acetobutylicum [21]. Nevertheless, the TCA cycles
of both organisms are different as no candidate
enzyme for the transfer of Coenzyme A to succinate
could be found in C. acetobutylicum. In addition, this
organism has putative genes for malate dehydrogenase
(EC 1.1.1.37) and 2-oxoglutarate synthase (EC 1.2.7.3)
[21–23], which are the missing enzymes in C. difficile
to close the TCA cycle.
Growth on 13C-labeled glucose – gluconeogenesis
is on despite glucose consumption
The model predicts only glucose and cysteine as car-
bon sources usable for biomass production in MDM,
whereas the other six amino acids are only used for
energy generation via Stickland reactions or directly
for protein synthesis. To study the carbon metabolism
of C. difficile in detail, the organism was grown in
naturally labeled MDM with completely 13C-labeled
glucose. The results of GC/MS analysis of some intra-
cellular metabolites in samples taken at optical density
(OD) 0.220 are shown in Fig. 3 (see Table S1 for
details). All detected metabolites along the connection
between cysteine and glucose were found either in the
completely labeled or the completely unlabeled form.
Fig. 2. The TCA cycle of C. difficile. For simplification not all substrates and products are shown. The direction of the arrows represents the
flux direction in C. difficile. Blue: metabolites of the TCA, white: other metabolites, green: reactions, gray: connected pathways.
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This indicates a recent switch between glycolysis and
gluconeogenesis during cultivation as under stable con-
ditions, the model predicts that the metabolites
between glucose and pyruvate are derived either from
glucose or from cysteine. The metabolites can be
divided into two groups. Glucose 6-phosphate is 64%
labeled and of the glycerate 3-phosphate, pyruvate,
lactate, and alanine only about 9% are labeled. This
indicates that the carbon of the central metabolism
and the glucose are merged at glucose 6-phosphate
with about 40% derived from gluconeogenesis. The
model predicts glucose 6-phosphate only degradable
via glycolysis, suggesting that the demand of activated
sugars is not satisfied by the glucose import at the time
of sampling.
Clostridioides difficile secretes an acetylated
glucose polymer
Initial modeling experiments using the experimental
metabolite import and export rates predicted a signifi-
cant higher growth rate (3.59 h1 instead of 0.414 h1
at 3 h of growth) compared to the experiment. In
addition, large amounts of carbon taken up by the
organism were not found in the known products or
biomass. Due to the viscous flow behavior of the cul-
ture supernatant and the temporarily active gluconeo-
genesis (see previous subsection), we suspected the
formation of a polysaccharide. Clostridioides difficile
possesses an operon putatively involved in the synthe-
sis of a polysaccharide. The operon consists of genes
encoding a putative membrane-bound O-acyl trans-
ferase (EC 2.3.1.-), a cellulose synthase (EC 2.4.1.12),
an endoglucanase (EC 3.2.1.4), and two membrane
proteins of unknown function. We assumed the gene
cluster to encode for enzymes responsible for the
biosynthesis of acetylated glucose polymer (putatively
acetylated cellulose).
To test this hypothesis, glucose and acetate concen-
tration of the culture supernatant were measured prior
and after acidic (for the depolymerization) and alka-
line (for acetate) hydrolysis. Table 3 shows that most
of the consumed glucose in both media is converted to
a polysaccharide consisting of acetylated glucose sub-
units. During cultivation in MDM, a constant 73%
share of the consumed glucose was converted to
polysaccharide. In CDMM, which contains additional
amino acids compared to MDM, the high glucose
uptake and polysaccharide synthesis were delayed and
the final ratio of synthesized polysaccharide to glucose
intake was only 40%. In both media, no degradation
of the polysaccharide by C. difficile could be detected
and approximately 0.5 mol acetate per mol polysac-
charide glucose was detected after alkaline hydrolysis.
These findings support the structure indicated by the
genome.
In agreement with the existence of a similar
operon (Table 2) in its genome, an acetylated
polysaccharide has been observed in cultures of
C. acetobutylicum [24]. In contrast to C. difficile,
C. acetobutylicum is able to degrade its polysaccha-
ride [24] and possesses a cellulosome. As C. aceto-
butylicum is unable to grow on cellulose [25] and its
cellulosome does not degrade crystalline cellulose
[26], its cellulosome is probably optimized to degrade
the secreted polysaccharide.
The growth-associated polysaccharide secretion
in MDM
The availability of time-resolved cultivation data of
C. difficile 630Derm [10] allows to use time-resolved
Fig. 3. Origin of carbon atoms in the
central metabolism. Abundances of
isotope labeling species at an OD of 0.220
with complete 13C-labeled glucose in
MDM. Blue: metabolites with determined
isotope labeling. The abundance of the full
13C-labeled species is given brackets,
white: other metabolites, green: reactions,
gray: connected pathways.
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FBA to investigate the metabolic state in more detail.
As the available growth data are more precise than
the polysaccharide production data, the simulations
for the growth were optimized for the synthesis of the
polysaccharide and the growth rate was set to growth
rates derived from literature [10]. Figure 4A shows the
glucose as well as the exopolysaccharide in the culture
broth during cultivation. The majority of the glucose
is converted to the exopolysaccharide. The model pre-
dicts 76% of the glucose uptake converted to polysac-
charide until an OD at 600 nm of 0.15 is reached.
This is close to the measured polysaccharide/glucose
ratio determined in the laboratory experiments
(Table 3). At an OD of 0.22, 81% of the consumed
glucose is predicted to be converted to polysaccharide,
which is slightly higher than experimentally deter-
mined.
Figure 4B shows the ratios of polysaccharide secre-
tion compared to glucose uptake and biomass produc-
tion in MDM during the linear growth phase, where
the increase of biomass is constant over time. The
model predicts a linear decrease of the ratio of pro-
duced polysaccharide sugar to glucose intake of 89%
(at 0.75 h) to 40% (at 8 h). This is temporarily inter-
rupted by a phase when more glucose is used for
polysaccharide synthesis than imported (Fig. 4). Here,
a switch from glycolysis to gluconeogenesis was
observed both in laboratory experiment and simula-
tion. As mentioned above, the amount of glucose 6-
phosphate derived from gluconeogenesis is about 40%
at OD 0.220 based on the laboratory experiment. The
model simulates this also quite accurately as 45% of
glucose 6-phosphate was derived from gluconeogenesis
at 5.75 h (OD 0.22).
The carbon ratio of the polysaccharide subunit
secretion rate and biomass production rate predicted
by the model (Fig. 4B) stays constant at
~13.1 molCmolC1 until 5 h of growth. After the sub-
sequent change of metabolism, the ratio stays constant
at ~2.6 molCmolC1 until 8 h of growth. Constant
ratios represent a growth-associated product formation
which indicates in turn the formation of a capsule or
biofilm. In fact, capsule [27] and biofilm [28] formation
have already been observed in different strains of
C. difficile. We observed stirring and shaking as
growth inhibiting effects for C. difficile cultures in our
laboratory (data not shown). The growth inhibiting
effect can be explained by the capsule formation, as
detached polysaccharide is replaced rather than new
biomass produced and C. difficile capsules were
reported to be fragile [27].
The glycolysis reaction fluxes are constant
during linear growth in MDM
The predicted activity of phosphoglycerate kinase (EC
2.7.2.3) is shown exemplarily in Fig. 4C. The flux
remains constant at about 24.5 mmol(gBiomass h)1
until 5 h of growth, drops below zero for about an
hour when the reaction flux is inverted during gluco-
neogenesis activity and slowly rises again to about
8.0 mmol(gBiomass h)1 until 7.5 h of growth. During
unrestricted exponential growth, all fluxes stay con-
stant over time. In contrast, C. difficile 630Derm
generates most of the biomass during a quasilinear
growth [10] when the growth rate drops nearly loga-
rithmically (Fig. 4C). Linear growth can be caused
by limited or constant supply of an essential
metabolite resulting in a constant activity of a single
enzyme or a system of enzymes requiring this
metabolite (e.g., vitamin B12) [29]. As C. difficile
was grown anaerobically in batch culture and all
substrates were fully solved, the latter can be ruled
out. Growth inhibiting reactions are difficult to iden-
tify as other reactions scale down analogously. As
the organism shows exponential growth in CDMM
(Table S4 and Fig. 5A), the limitation of an amino
acid biosynthesis has to be the reason for linear
growth. A constant glycolysis is nevertheless remark-
able. As glucose is constantly taken up for synthesis
of the secreted polysaccharide, glucose 6-phosphate
is available in the cell. The glycolysis activity is






(%)C. difficile C. acetobutylicum
Membrane protein CDIF630erm_02794 CA_C1565 51 93
Putative membrane-bound
O-acyl transferase
CDIF630erm_02795 CA_C1564 61 100
Membrane protein CDIF630erm_02796 CA_C1562 27 90
Cellulose synthase CDIF630erm_02797 CA_C1561 53 95
Endoglucanase CDIF630erm_02798 CA_C1563 46 17
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therefore explainable by a constitutive presence of
glycolysis enzymes, acting nearly at their maximum
speed.
Alanine secretion is an unintended side effect
After the metabolic switch at 5 h of growth, when the
amino acid uptake is significantly increased, alanine is
secreted by C. difficile in MDM [10]. The model pre-
dicts the degradation of alanine to be more favorable
than its secretion at all time points of cultivation. The
alanine secretion is hence probably an unintended side
effect: the increased glutamate dehydrogenase demand
due to the change in the substrate uptake is putatively
not instantly satisfiable. To recreate the necessary
amount of 2-oxoglutarate, other oxoacids are ami-
nated instead, leading to the secretion of the relatively
small molecule alanine as an overflow metabolite.
The model accurately simulates growth in
CDMM
As no polysaccharide was secreted in CDMM during
the exponential growth phase (Table 2), the
Table 3. Polysaccharide formation in MDM and CDMM. The initial
glucose concentration was determined to be 11.48  0.10 mM in
MDM and 11.68  0.14 mM in CDMM.
Medium
MDM
Growth phase Early Late Stationary
OD (600 nm) 0.151 0.218 0.377
Glucose prior
hydrolysis [mM]
5.16  0.19 2.10  0.16 0.24  0.08
Glucose after
hydrolysis [mM]
9.82  0.16 8.88  0.16 8.54  0.19
Acetate prior
hydrolysis [mM]
1.36  0.16 2.14  0.06 5.88  0.27
Acetate after
hydrolysis [mM]
3.87  0.09 5.06  0.07 9.18  0.09
Glucose
(bound/total)
0.73  0.05 0.72  0.03 0.74  0.02
Acetylations per
bound glucose
0.54  0.05 0.43  0.02 0.39  0.04
Medium
CDMM
Growth phase Early Late Stationary
OD (600 nm) 0.326 0.725 1.169
Glucose prior
hydrolysis [mM]
11.47  0.26 3.05  0.12 0.07  0.14
Glucose after
hydrolysis [mM]
11.49  0.31 6.13  0.19 4.70  0.50
Acetate prior
hydrolysis [mM]
2.37  0.05 14.01  0.41 18.89  0.24
Acetate after
hydrolysis [mM]
2.35  0.11 15.88  0.33 21.05  0.26
Glucose
(bound/total)
– 0.36  0.03 0.40  0.05
Acetylations per
bound glucose




Fig. 4. Growth of C. difficile 630Derm in MDM. (A) Orange:
glucose concentration used for the simulations, blue: predicted
exopolysaccharide concentration. (B) Blue: predicted ratio of
polysaccharide sugar secretion rate and glucose uptake rate (PS/
Glc), green: predicted ratio of polysaccharide carbon secretion rate
and biomass carbon production rate (PS/BM). (C) Green: growth
rate based on OD, orange: predicted reaction flux catalyzed by the
phosphoglycerate kinase (EC 2.7.2.3) per biomass.
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simulations were optimized for biomass generation.
After the metabolic switch at 3.5 h (see also Table S4),
connected to an increase of glucose uptake, the maxi-
mization of polysaccharide secretion was the objective
of optimization. The predicted growth rates are similar
to the experimentally determined ones (Fig. 5A). The
nearly constant growth rate of 1.0 h1 between 1.5
and 3.33 h indicates a strictly exponential growth. The
model also predicts 33% of the imported glucose until
4 h of growth to be bound in the secreted polysaccha-
ride. This is in the range of the 36  3% experimen-
tally determined at an OD of 0.725, after 4 h of
growth. The predicted amounts of the produced vola-
tile fatty acids (Fig. 5B) are also in agreement with
laboratory results. Leucine is first degraded using the
oxidative Stickland pathway (Fig. 5A) and later
degraded by both pathways and finally only degraded
using the reductive Stickland pathway (Fig. 5B). In
addition, after 3 h of growth, butanoate production is
started and the production of acetate and propanoate
is discontinued, leading to an acetate concentration of
12.81 mM in the linear growth phase, which is close to
the 14.01  0.41 mM determined in laboratory experi-
ment (Table 2).
The reductive acetyl-CoA pathway and its
importance
In the reductive acetyl-CoA pathway, also known as
Wood–Ljungdahl pathway, acetyl-CoA is reductively
generated from a one-carbon group and CO2. In this
pathway, the one-carbon group is bound to a tetrahy-
drofolate. In the model iHD992, this group can either
originate from formate, using the complete pathway,
or originate from amino acids and arrive the pathway
at 5,10-methylene-tetrahydrofolate. 5,10-methylene-tet-
rahydrofolate can be formed from tetrahydrofolate by
the glycine hydroxymethyltransferase (EC 2.1.2.1),
which degrades L-serine to glycine, or by the glycine-
cleavage-complex. In addition, the degradation of thre-
onine by L-threonine aldolase (EC 4.1.2.5) also leads
to glycine.
As long as the necessary one-carbon groups to
regenerate 5,10-methylene-tetrahydrofolate from
tetrahydrofolate are available, C. difficile uses the
Wood–Ljungdahl pathway as primary electron sink.
The activity of the acetyl-CoA synthase complex (EC
2.3.1.169), the terminal enzyme of the reductive acetyl-
CoA pathway, is nearly constant between 1.0 and
3.0 h of growth (Fig. 5C). In contrast, the sources of
one-carbon groups vary. However, in the beginning
~50% originate from threonine and glycine. At a later




Fig. 5. Simulation results of C. difficile 630Derm growth in CDMM.
(A) Green: growth rate based on OD, orange: predicted growth
rate, blue: predicted glucose converted to secreted polysaccharide
per total consumed glucose. (B) Predicted side products
concentrations over time. For simplification, side product secretion
prior 0.4 h was neglected. Blue: acetate, green: propanoate,
orange: butanoate, yellow: isovalerate, gray: isocaproate, black:
pentanoate. (C) Fluxes related to reductive acetyl-CoA biosynthesis
per biomass. Amino acid uptake rates are derived from laboratory
experiment. Yellow: predicted activity of the acetyl-CoA synthase
complex (EC 2.3.1.169), green: serine uptake, blue: threonine
uptake, orange: glycine uptake, gray: predicted activity of the
methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5), black:
theoretical one-carbon availability based on amino acid uptake and
methylenetetrahydrofolate dehydrogenase activity.
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increases until serine is taken up in significant amounts
and nearly solely provides the necessary methyl
groups.
Clostridioides difficile ATP synthases contain at
least 12 c subunits
Several H+/ATP and Na+/ATP ratios of the ATP
synthases were tested in the model for the best repro-
duction of the laboratory results. Eventually, both
ratios were set to 4, as – according to model prediction
– 3.33333 or lower ratios would lead to butanoate pro-
duction instead of reductive acetyl-CoA synthesis and
at 3.66667 the propanoate production would be more
favorable than butanoate production.
Alternatively, a acryloyl-CoA reductase without
the electron bifurcation mechanism, leading to an
energetically less feasible propanoyl-CoA pathway,
would also cause butanoate production at an Ion/
ATP ratio of 3.66667. It has been shown that the
enzyme of Clostridium propionicum can act without
bifurcation [30]. In addition, it was suggested that
the enzymes of C. propionicum and Clostridium ho-
mopropionicum do not bifurcate [31]. Nevertheless,
the structure of the enzyme, consisting of a catalytic
subunit as well as the EtfA and EtfB, clearly indi-
cates an electron bifurcation mechanism as other
complexes with EtfA and EtfB bifurcate electrons
[32–34].
The most striking indication for an electron bifur-
cating acyloyl-CoA reductase in C. difficile is the
production of pentanoate after 2.5 h of growth in
CDMM reported by Neumann-Schaal et al. [10]:
Pentanoate can only be formed by the enzymes of
the butanoate fermentation pathway using acetyl-
CoA and propanoyl-CoA as substrates. Using a acy-
loyl-CoA reductase without electron bifurcation is
less energy efficient than forming butanoate, leading
to no propanoyl-CoA and thus no pentanoate for-
mation.
The amount of imported protons or sodium ions
per three ATP molecules formed is equal to the num-
ber of c subunits in the ATP synthase complex [35].
We therefore conclude that C. difficile possesses at
least 12 c subunits per ATP synthases. The number of
c subunits is organism-specific and can have any value
between 10 and 15 [36–41] resulting in a ratio of 3⅓
and 5. A low ratio is more energy efficient, what is
especially important for anaerobic organisms using
Stickland reactions like C. difficile. These organisms
generate organic acids as byproducts and therefore
generate less ATP per mole substrate than aerobic
organisms.
Conclusions
The simulation results presented in this paper were
achieved using a newly constructed model of C. diffi-
cile 630Derm and DFBA. It could been shown that
quantitative growth and product secretion can be accu-
rately predicted under different growth conditions in a
time-resolved manner. Thus, the quality of available
C. difficile simulations was significantly enhanced.
Clostridioides difficile has remarkably metabolic
peculiarities. The organism possesses a fragmented
TCA cycle which is still capable to produce all meta-
bolic precursors. In addition, the reductive acetyl-CoA
synthesis pathway is used for the depletion of nearly
all excess electrons from oxidations under most of the
growth conditions. The model shows the decrease of
the reductive acetyl-CoA synthesis pathway due to a
lack of methyl donors during growth in CDMM. As a
result, butanoate is produced instead to utilize excess
electrons. This might explain the observed coupling of
butanoate activity and toxin production [8,9]. The
organism could be in need of methyl donors for the
preferred reductive acetyl-CoA synthesis pathway and
starts to produce toxins, making the necessary amino
acids available by damaging host cells.
In this paper, we describe the composition and
growth coupled formation of a previously unknown
exopolysaccharide of C. difficile. As several strains of
C. difficile have been reported to produce capsules [27]
and form biofilms [28], this polymer could be involved
in both processes. As C. difficile in biofilms has been
shown to be more resistant to vancomycin [28], the
understanding and inhibition of biofilm formation is
of medical importance.
Materials and methods
Strains, media, and growth conditions
All studies were carried out with C. difficile 630Derm
(DSM28645) [13] obtained from the Deutsche Sammlung
von Mikroorganismen und Zellkulturen (DSMZ, Braun-
schweig, Germany). The media and growth conditions were
described earlier [10].
Quantification of biomass components
DNA, RNA, and protein content were quantified as
described earlier [42] with a prolonged lysozyme incubation
for DNA quantification of 4 h.
Estimation of amino acid composition was adapted
from Lee et al. [43]. A cell pellet corresponding to
approximately 1.7 mg cell dry weight was washed twice
with 0.9% NaCl (w/v), resuspended in 200 lL HCl
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(6 M), and hydrolyzed for 24 h at 99 °C. Following neu-
tralization, HPLC measurement of released amino acids
and meso-diaminopimelate was performed as previously
described [44] with modifications to optimize the perfor-
mance for acidic hydrolyzed samples: The mobile phase
A was changed to 10 mM sodium acetate (pH 6.5) and
the gradient was altered to 3% for 5.3 min, 3–6% within
0.05 min, 6–7% within 4.65 min, 7% for 1 min, 7–15%
within 1 min, 15% for 10 min, 15–25% within 0.5 min,
25% for 2 min, 25–30% within 2.5 min, 30–100% within
0.1 min, and 100% for 2.9 min. To determine the con-
centration of released meso-diaminopimelate, a calibration
curve was prepared in the range of 5–300 lM. The gradi-
ent was altered between 11 and 22 min as follows: 7–
14% within 1 min, 14% for 2.5 min, 14–15% within
0.25 min, and 15% for 7.25 min.
Lipids were extracted according to the protocol of
Matyash et al. [45] and quantified gravimetrically. Dried
biomass was correlated gravimetrically to the optical den-
sity of samples determined with a GENESYS 10S spec-
trophotometer (Thermo Fisher Scientific, Waltham, MA,
USA).
Polysaccharide analysis
Cell-free culture supernatants were obtained during expo-
nential, transient, and stationary growth phase from three
individual biological samples.
Alkaline hydrolysis was adapted from H€aggstr€om and
F€orberg [24] with some modifications. Culture supernatants
were mixed with 1.5 volumes of 5 M NaOH and incubated
for 2 h at 22 °C followed by a neutralization step using the
same volume of 5 M H2SO4. For reference samples without
hydrolysis, culture supernatants were diluted with three vol-
umes of an 1 : 1 mixture of NaOH (5 M) and H2SO4 (5 M).
Medium samples were used as blanks. Samples were ana-
lyzed using the Roche Yellow line Acetic Acid kit (R-Bio-
pharm, Darmstadt, Germany). Each biological sample was
measured in triplicates.
For glucose determination, an acidic hydrolysis was per-
formed to avoid alkaline degradation of glucose [46].
Hydrolysis procedure was adapted from Cohen and John-
stone [47] with some modifications. Culture supernatant
was mixed with three volumes of 95% H2SO4, incubated
on ice for 10 min, heated to 99 °C for 20 min, and cooled
to 22 °C prior to neutralization with NaOH. For reference
samples without hydrolysis, culture supernatant samples
were diluted with premixed H2SO4 and NaOH solutions.
Medium samples were used as reference for the initial glu-
cose concentrations. Medium samples without glucose addi-
tion were used as blanks. Samples were prepared and
analyzed using the Roche Yellow line Acetic Acid kit (R-
Biopharm) as described earlier [10]. Each biological sample
was measured in triplicates.
GC/MS-based analysis
Cell extracts were prepared and analyzed as described pre-
viously [15]. The peak identification was performed tar-
geted with a combined compound library. Isotope patterns
were corrected for naturally occurring isotope distribution
regarding silicon and carbon atoms. Natural isotopes with
less than 0.5% relative abundance were neglected.
Model generation
Reactions corresponding to the annotated gene functions
[15] in C. difficile 630Derm were taken from BKM-react
[48] and supplemented with additional reactions from liter-
ature. The resulting reaction list was carefully filtered for
metabolically redundant or energetically infeasible reactions
and reaction combinations. Reactions implied by unspecific
EC numbers but not by more specific product names were
excluded as well as side reactions with metabolites not
known in C. difficile or related organisms. Gaps were
closed manually and as stingy as possible. Transporters
were included whenever annotated, experimental evidence
was existent or a transporter was strictly necessary.
Biomass composition
The amount of protein, DNA, RNA, and total lipid in the
biomass was determined experimentally. To get the full
amino acid content of biomass, the measured amino acid
content of hydrolyzed cells were modified assuming the mea-
sured glutamate was glutamate and glutamine in a mass ratio
of 4 : 1, the aspartate was aspartate and asparagine in the
mass ratio of 1 : 1, and the mass ratios of histidine, cysteine,
tryptophan, and selenocysteine were 100 : 80 : 80 : 1.
Assuming all meso-diaminopimelate was part of the peptido-
glycan, corresponding amounts of glutamate, alanine, and
glycine according to the peptidoglycan structure of C. diffi-
cile 630 [49] were subtracted to get the amino acid composi-
tion of the proteins. Based on this and the total protein
concentration, the meso-diaminopimelate content of the bio-
mass was corrected and used to calculate amount of peptido-
glycan in the biomass (14.5%). The ratio of the
peptidoglycan and the cell wall polysaccharide II [50] was set
to 4 : 6 [51]. The nucleotide demand for rRNA and tRNA
was calculated from the corresponding genes and for DNA
and mRNA from the chromosome sequence of C. difficile
630Derm [15]. The methylation of the DNA was estimated
from literature [14] to be 8000/genome. The relative amounts
of the different RNAs were adapted from E. coli [52]. The
proportions of methylation and hydrogenation (23S rRNA:
E. coli, 16S rRNA: C. acetobutylicum, tRNA: Bacillus sub-
tilis) were taken from the MODOMICS database [53]. The
previously characterized lipoteichoic acid [54] was assumed
to be part of the total lipid with a ratio of 8 : 20 to the
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phospholipids as in B. subtilis [55]. As phosphatidylglycerol
analogs were found in C. difficile isolates [56] and the model
only includes reactions for the biosynthesis of phosphatidyl-
glycerol and cardiolipin, an equimolar ratio of both lipids in
C. difficile was assumed. The fatty acid chain length of
16.246 °C and the proportion of unsaturated fatty acids of
16.4% were calculated from literature [57]. Glycogen was
postulated to be 0.5% of the biomass. For simplification, we
constructed the metabolite pool only out of cofactors and
other putative important metabolites for growth otherwise
not build by the model. The ratios of these metabolites were
adapted from C. acetobutylicum in the acidogenic phase [58]
and the amounts of metabolites not quantified were assumed
to the equal to each other and to FAD quantified in C. ace-
tobutylicum [58]. As polymer precursors and all intermediates
were neglected in the metabolite pool, the amount of
metabolites in the biomass had to be underestimated. The
demand of metabolites and ions was set to 0.5% and 2.2%,
respectively. For the ion composition, values from B. subtilis
were used [55] and complemented with Na+, Fe2+, Ni2+,
Cd2+, and Zn2+ (1% each). The composition of biomass
can be found in detail in Table S4.
Energy requirements
For a metabolic model capable of describing the energy
metabolism and quantitative growth, suitable values for the
maintenance energy are required. Growth-associated main-
tenance (GAM) and nongrowth-associated maintenance
(NGAM) energies are usually calculated from chemostate
cultures at different dilution rates [59]. As these data are
not available for C. difficile, the NGAM was estimated as
the average (2 mmol(gBiomass h)1) of five anaerobic rumen
bacteria [60], assuming 3.3 ATP/glucose for mixed butano-
ate/acetate fermentations [31]. As the GAM is strongly
dependent on the substrates supplied and the biomass com-
position of the organism, literature data could not be used.
Several values for the GAM were tested and eventually the
GAM was set to 45 mmol(gBiomass h)1, leading to the
most in vivo similar results.
Data analysis for modeling
Optical densities and relative substrate concentrations
during the cultivation of C. difficile 630Derm were derived
from literature [10]. The values were fitted with the ORIG-
INPRO 2015G software (OriginLab, Northampton, MA,
USA). The resulting functions of the OD and metabolite
concentrations can be found in Table S3 and S4. When
necessary, the data of different time frames were fitted
separately to get the best mathematical description. The
functions were used to compute the concentrations
including the OD every 15 min starting at 7.5 min
(MDM) or 10 min starting at 5 min (CDMM). Relative
substrate concentrations were converted to absolute
concentrations setting the concentration at time point
zero at the concentration in the initial medium. The bio-
mass was calculated using the correlation of 0.425 gL1
biomass dry weight per optical density unit at 600 nm
wavelength.
(Time-resolved) flux balance analysis
Flux balance analysis, extensively described elsewhere [61],
was used to analyze the physiological states of C. difficile
630Derm. The metano toolbox [62] was used for all simula-
tions. For the simulation of the complex growth behavior
in batch cultures, DFBA (see Antoniewicz [63] for details)
was used. As objective function was either the biomass
generation equation used or the secretion of the expolysac-
charide with a fixed biomass generation flux derived from
laboratory experiment. In contrast to earlier published
DFBA methods [17,18], the substrate consumption and
some production rates were given as constrains at each
time interval. These rates were derived from the fits of the
measured substrate and product concentrations over time,
similar to the dynamic metabolic flux analysis used to
describe the behavior of E. coli during change of the limit-
ing substrate [64].
For the modeling of the biosynthesis of the secreted
polysaccharide, UDP-glucose was used as substrate for the
polymerization, every second glucose subunit was acety-
lated with acetyl-CoA and the hydrolysis of one ATP was
assumed as transport cost per glucose subunit across the
membrane. To calculate the total conversion of glucose to
polysaccharide in MDM, 90% of the taken up glucose
prior to the linear growth phase was assumed. The fatty
acid synthesis was restricted to use only acetyl phosphate
as starter molecule to prevent large-scale synthesis of fatty
acids with up to six carbon atoms via the Stickland reac-
tions and the butanoate pathway.
For the correct reproduction of the experimental data in
CDMM, two predefinitions had to be made. First, for an
accurate simulation of the side product secretion in
CDMM, the methylenetetrahydrofolate dehydrogenase
(NADP+, EC 1.5.1.5) had to be deactivated after 2.5 h of
growth to prevent the refilling of the one-carbon-pool from
formate. The reason for the inactivation of this pathway
in vivo remains unclear. Second, the production of pro-
panoate and hexanoate via the butanoate fermentation
pathway had to be limited: the maximal fluxes of the
acetyl-CoA C-acetyltransferase (EC 2.3.1.9) for the sub-
strates propanoyl-CoA and butanoyl-CoA were set to 1/3
and 1/20 of the flux with acetyl-CoA as the substrate.
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